Tuesday, March 06, 2018 9:44:54 AM
How far do you think Pluristem is away from ever having a shot at this? They did this so they have an "oncology" product, in the hopes that it would garner attention. It didn't. Nothing does. No controller necessary here. Sleeping giant is one fail away from life support.
We are in a time of medical miracles coming from everywhere. Companies with deep pockets, experienced management, and the know how to advance their products quickly. We have the "fast track" on several, but just like the PMDA that's been sitting idle for years, we just move along at a normal pace. We are not alone in getting these "fast track" designations. Do you think others are moving slowly like we are. I don't. We are what, 2 years waiting for Sosei to close. Pathetic.
IC results better be stellar to say the least. Mediocre results just won't cut it. They need great results to increase share price for further dilutions, or that promised partnership they've been touting for many years now. Failing that, it would leave us with ARS as our only hope, without more increasingly painful dilutions to get through to the half way point to CLI. And if IC results aren't that great, what hope is there for CLI.
As always, we have to wait and see, all while others catch up and/or overtake us on our products. Management did us no good in their 2 year delay in building out manufacturing. Time is of the essence and they made poor decisions that have put our price where it is. Stagnant like nothing else I have ever seen in the biotech space.
So no, we are not alone and I'm truly NOT ok with it. How anyone justifies this management and the decisions they have made is remarkable. I guess that's why nobody does with any claims other than they're "ok" with it. Jokes.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM